Here is another question for the CC regarding NGIO and Merck. What is the long range or intermediate plan for NGIO and Merck if the trial results are looking positive? At the last CC it was mentioned that Merck would increase their involvement, but what does that look like. Is everyone assuming Merck would acquire NGIO? If so how does that work with GNBT still owning up to 60%?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links